Legend biotech (LEGN.US) is expected to have a net loss of approximately $94.7 million to $0.1097 billion after adjustment in the first half of 2024.
According to the Zhitongcaijing APP, Legend biotech (LEGN.US) is expected to have a net loss of approximately $94.7 million to $0.1097 billion after adjustment in the first half of 2024. The company also expects a net loss of $75.4 million to $87.4 million in the first half of 2024.
Legend biotech will release its six-month financial report ending on June 30, 2024 on August 9.
As of press time, Legend biotech fell nearly 1% at the beginning of the session.